WGS has been employed to analyze rearrangements in SMM, discovering that only IGH-MYC rearrangements confer a high risk of SMM progression [100] and complex rearrangements were discovered to be equally present in SMM than in MM but with a lower cancer cell fraction in the first [3]. The gene discussed is MYC; the disease is Miyoshi myopathy.